Physician profile
Victor R Davila
NPI 1174787329
$21,941.08
in general payments reported to CMS, 2019-2025
7 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.00 · 2021: $89.85 · 2023: $19.81 · 2024: $9,423 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $7,025 · Food and Beverage: $757 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,000.00 |
| Travel and Lodging | $7,024.95 |
| Food and Beverage | $757.47 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $20,564.65 | 2024-2025 | A5 Anesthesia System, Te7 Max, Te X |
| Abiomed | $1,073.41 | 2025 | |
| Werfen USA LLC | $128.74 | 2024 | |
| Heron Therapeutics, INC. | $89.85 | 2021 | |
| La Jolla Pharmaceutical Company | $49.00 | 2020 | |
| Merck Sharp & Dohme LLC | $19.81 | 2023 | Bridion |
| Medtronic, INC. | $15.62 | 2024 | Mc3 Nautilus(Tm) Ecmo Oxygenator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Davila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.